1356929-59-3
1356929-59-3
Chemical Structure
Perindopril-d4 erbumine
- CAS No.: 1356929-59-3
- Formula:C23H39D4N3O5
- Molecular Weight:445.63
IUPAC Name: 2-methylpropan-2-amine (2S,3aS,7aS)-1-(((S)-1-ethoxy-1-oxopentan-2-yl)-L-alanyl-2,3,3,3-d4)octahydro-1H-indole-2-carboxylate
InChIKey: IYNMDWMQHSMDDE-LJPFWORXSA-N
SMILES: CC(C)(N)C.CCOC([C@H](CCC)N[C@](C([2H])([2H])[2H])([2H])C(N1[C@]2([H])[C@](CCCC2)([H])C[C@H]1C(O)=O)=O)=O
Biological Activity: Perindopril-d4 t-butylamine salt is the deuterium labeled Perindopril t-butylamine salt. Perindopril t-butylamine salt is a long-acting ACE inhibitor of which is used to treat high blood pressure, heart failure or stable coronary artery disease[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Perindopril-d4 erbumine | Perindopril-d4 t-butylamine salt is the deuterium labeled Perindopril t-butylamine salt. Perindopril t-butylamine salt is a long-acting ACE inhibitor of which is used to treat high blood pressure, heart failure or stable coronary artery disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Perindopril erbumine (Standard) | ≥98% | Perindopril (erbumine) (Standard) is the analytical standard of Perindopril (erbumine). This product is intended for research and analytical applications. Perindopril erbumine is an angiotensin-converting enzyme inhibitor. Perindopril erbumine modulates NF-κB and STAT3 signaling and inhibits glial activation and neuroinflammation. Perindopril erbumine can be used for the research of Chronic Kidney Disease and high blood pressure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Perindopril-d3 erbumine | Perindopril-d3 (erbumine) is deuterated labeled Perindopril (erbumine) (HY-B0130A). Perindopril erbumine is an angiotensin-converting enzyme inhibitor. Perindopril erbumine modulates NF-κB and STAT3 signaling and inhibits glial activation and neuroinflammation. Perindopril erbumine can be used for the research of Chronic Kidney Disease and high blood pressure. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Perindopril erbumine | 99.98% | Perindopril erbumine is an angiotensin-converting enzyme inhibitor. Perindopril erbumine modulates NF-κB and STAT3 signaling and inhibits glial activation and neuroinflammation. Perindopril erbumine can be used for the research of Chronic Kidney Disease and high blood pressure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Vaclavik J, Perindopril in the treatment of hypertension and cardiovascular diseases: evolution continues with the orodispersible dosage form. Vnitr Lek. 2013 Apr;59(4):290-4. [Content Brief]
